Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- JNJ last traded at $270.47 on 2026-11-20, 1.25% for the session.
- Johnson & Johnson: market cap $651.11B, P/E 40.5, revenue $99.33B over the last four quarters, next earnings 2027-01-26.
- Over the past year JNJ returned 33.56%, with a year-to-date return of 30.69%.
TREMFYA data and drug filing lift J&J shares
Johnson & Johnson rose 1.3% today, even as the S&P 500 fell 3.8% and the Nasdaq 100 fell 5.5%. Fresh TREMFYA results and a new FDA filing for CAPLYTA put its drug pipeline in focus; the next report is Jan 26, 2027 before the open.
Published 2026-11-20 21:30:25 UTC.